Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target

Vaccine

Volumn 23, Issue 48-49, 2005, Pages 5599-5617

  Manocha, Monika ^a   Pal, Pramod Chandra ^a   Chitralekha, K T ^a   Thomas, Beena Elizabeth ^a   Tripathi, Vinita ^a   Gupta, Siddhartha Dutta ^a   Paranjape, Ramesh ^b   Kulkarni, Smita ^b   Rao, D Nageswara ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL AIDS RESEARCH INSTITUTE   (India)

Author keywords

Microparticle; Peptide; Secretory IgA; Ulex Europaeus I lectin

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LEUCINE ZIPPER PROTEIN; NEF PROTEIN; PEPTIDE DERIVATIVE; PLANT LECTIN; POLYGLACTIN; ULEX EUROPAEUS AGGLUTININ; VIRUS FUSION PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; COMPARATIVE STUDY; CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; FEMALE; FEVER; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; LAMINA PROPRIA; MICROPARTICLE ENZYME IMMUNOASSAY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TRANSPORT; SEXUAL TRANSMISSION; SPLEEN; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADMINISTRATION, INTRANASAL; AIDS VACCINES; ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; HIV ANTIBODIES; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; HIV-1; IMMUNITY, MUCOSAL; MICE; MICE, INBRED BALB C; MICROSPHERES; PEPTIDE FRAGMENTS; PLANT LECTINS; POLYGLYCOLIC ACID;

EID: 27744548806     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.06.031     Document Type: Article

References (51)

1. P.A. Kozlowski, and M.R. Neutra The role of mucosal immunity in prevention of HIV transmission Curr Mol Med 3 2003 217 228
2. C. Devito, J. Hinkula, R. Kaul, J. Kimani, P. Kiama, and L. Lopalco Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects J Acquir Immune Defic Syndr 30 2002 413 420
3. C. Lue, A.W. van den Wall Bake, S.J. Prince, B.A. Julian, M.L. Tseng, and J. Radl Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response Clin Exp Immunol 96 1994 356 363
4. A.S. Bourinbaiar, O. Metadilogkul, and V. Jirathitikal Mucosal AIDS vaccines Viral Immunol 16 2003 427 445
5. N. Vincent, E. Malvoisin, B. Pozzetto, F. Lucht, and C. Genin Detection of IgA inhibiting the interaction between gp120 and soluble CD4 receptor in serum and saliva of HIV-1-infected patients AIDS 18 2004 37 43
6. Z. Durrani, T.L. McInerney, L. McLain, T. Jones, T. Bellaby, and F.R. Brennan Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization J Immunol Methods 22 1998 93 103
7. Y. Hirabayashi, H. Kurata, H. Funato, T. Nagamine, C. Aizawa, and S. Tamura Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination Vaccine 8 1990 243 248
8. H. Kato, H. Bukawa, E. Hagiwara, K.Q. Xin, K. Hamajima, and S. Kawamoto Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses Vaccine 18 2000 1151 1160
9. I.M. Belyakov, M.A. Derby, J.D. Ahlers, B.L. Kelsall, P. Earl, and B. Moss Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge Proc Natl Acad Sci USA 95 1998 1709 1714
10. J.H. Eldridge, C.J. Hammond, J.A. Meulbroek, J.K. Staas, R.W. Gilley, and T.R. Tice Controlled vaccine released in the gut-associated lymphoid tissue. I. Orally administered biodegradable microspheres target the peyer's patches J Control Release 11 1990 205 214
11. E.C. Lavelle, G. Grant, A. Pusztai, U. Pfuller, O. Leavy, and E. McNeela Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2 Immunology 107 2002 268 274
12. R.L. Owen Uptake and transport of intestinal macromolecules and microorganisms by M cells in Peyer's patches-a personal and historical perspective Semin Immunol 11 1999 157 163 Review
13. S. Ghosh Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease Adv Drug Deliv Rev 9 2004 915 920 Review
14. H.M. Amerongen, R. Weltzin, C.M. Farnet, P. Michetti, W.A. Haseltine, and M.R. Neutra Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS J Acquir Immune Defic Syndr 4 1991 760 765
15. C. Pastori, C. Barassi, S. Piconi, R. Longhi, M.L. Villa, and A.G. Siccardi HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket J Biol Regul Homeost Agents 14 2000 15 21
16. Y.M. Chen, R.H. Lin, C.M. Lee, C.Y. Fu, S.C. Chen, and W.J. Syu Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression AIDS Res Hum Retroviruses 15 1999 43 50
17. I. Lemasson, V. Housset, and B.D. Calas Antigenic analysis of HIV type 1 external envelope (Env) glycoprotein C2 region: implication for the structure of Env AIDS Res Hum Retroviruses 11 2001 1177 1186
18. B.E. Thomas, M. Manocha, W. Haq, T. Adak, C.R. Pillai, and D.N. Rao Modulation of humoral response to repeat and non-repeat sequences of CS protein with novel adjuvant and delivery system(s) Ann Trop Med Parasitol 95 2001 573 586
19. H.F. Staats, S.P. Montgomery, and T.J. Palker Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses AIDS Res Hum Retroviruses 13 1997 945 952
20. H. Kiyono, J.R. McGhee, L.M. Mosteller, J.H. Eldridge, W.J. Koopman, and J.F. Kearney Murine Peyer's patch T cell clones. Characterization of antigen-specific helper T cells for immunoglobulin A responses J Exp Med 1 156 1982 1115 1130
21. J. Li, K.A. Kudsk, B.D. Gocinski, D. ent, J. Glezer, and B. Langkamp-Henken Effects of parenteral and enteral nutrition on gut-associated lymphoid tissue J Trauma 39 1995 44 51
22. R. Kaul, D. Trabattoni, J.J. Bwayo, D. Arienti, A. Zagliani, and F.M. Mwangi HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers AIDS 14 1999 23 29
23. C. Devito, K. Broliden, R. Kaul, L. Svensson, K. Johansen, and P. Kiama Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells J Immunol 1 2000 5170 5176
24. K. Gokulan, and D.N. Rao Bioactive fragment of human IL-1beta [163-171] modulates the immune response to synthetic peptides of HIV Microbiol Immunol 41 1997 965 974
25. K. Gokulan, S. Khare, and D.N. Rao Increase in the immunogenicity of HIV peptide antigens by chemical linkage to polytuftsin (TKPR40) DNA Cell Biol 18 1999 623 630
26. L. Agrawal, W. Haq, C.V. Hanson, and D.N. Rao Generating neutralizing antibodies. Th1 response and MHC non-restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity Immune Ther Vaccine 1 2003 5
27. M. Pizza, M.M. Giuliani, M.R. Fontana, E. Monaci, G. Douce, and G. Dougan Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants Vaccine 21 2001 2534 2541
28. A.V. Capozzo, L. Cuberos, M.M. Levine, and M.F. Pasetti Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers Infect Immun 72 2004 4637 4646
29. D.T. O'Hagan Intestinal translocation of particulate-implications for drug and antigen delivery Adv Drug Deliv Rev 5 1990 265 285
30. J.M. Phillips-Quagliata, and M.E. Lamm Lymphocyte harming to mucosal effector sites P.L. Ogra W. Strober J. Mestecky J.R. McGhee M.E. Lamm J. Bienenstock Handbook of mucosal immunology 1994 Academic Press San Diego CA 225 239
31. L.E. Brown, D.O. White, C. Agius, B.E. Kemp, N. Yatzakis, and P. Poumbourios Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses Arch Virol 140 1995 635 654
32. C.B. Morris, E. Cheng, A. Thanawastien, L. Cardenas-Freytag, and J.D. Clements Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT (R192G) Vaccine 17 2000 1944 1951
33. M.B. Mazanec, J.G. Nedrud, C.S. Kaetzel, and M.E. Lamm A three-tiered view of the role of IgA in mucosal defense Immunol Today 14 1993 430 435
34. J.P. Vaerman, J.F. Heremans, H. Bazin, and A. Beckers Identification and some properties of rat secretory component J Immunol 114 1975 265 269
35. T.F. Gajewski, M. Pinnas, T. Wong, F.W. Fitch, and Murine Th1 Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations J Immunol 146 1991 1750 1758
36. J.L. Munoz, C.A. McCarthy, M.E. Clark, and C.B. Hall Respiratory syncytical virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells J Virol 65 1991 4494 4497
37. Y. Yamaguchi-Kabata, and T. Gojobori Re-evaluation of amino acid variability of the human immunodeficiency virus type 1 gp120 envelope glycoprotein and prediction of new discontinuous epitopes J Virol 74 2000 4335 4350
38. A. Vahlne, P. Horal, K. Eriksson, S. Jeansson, L. Rymo, and K.G. Hedsform Immunization of monkey with synthetic peptides disclosed conserved areas on gp120 of human immunodeficiency virus type-I associated with cross neutralizing antibodies and T cell recognition Proc Natl Acad Sci USA 88 1991 10744 10748
39. E. Nardin, P. Clavijo, B. Mons, A. Van Belkum, T. Ponnudurai, and R.S. Nussenzweig T cell epitopes of the circumsporozoite protein of Plasmodium vivax recognition by lymphocytes of a sporozoite-immunized Chimpanzee J Immunol 146 1991 1674 1678
40. E.H. Nardin, P.J. Barr, E. Heimer, and H.M. Etlinger Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein Eur J Immunol 18 1988 1119 1122
41. J.A. Berzofsky Intrinsic and extrinsic factors in protein antigenic structure Science 229 1985 932 940
42. S.A. Cumming, D.A. McPhee, W.J. Maskill, B.E. Kemp, R.R. Doherty, and I.D. Gust Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies AIDS 4 1990 83 86
43. S.J. Bell, D.A. Cooper, B.E. Kemp, R.R. Doherty, and R. Penny Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1 Clin Exp Immunol 87 1992 37 45
44. J. Choppin, F. Martinon, E. Gomard, E. Bahraoui, F. Connan, and M. Bouillot Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides J Exp Med 172 1990 889 899
45. V. Pancre, B. Georges, G. Angyalosi, F. Castelli, A. Delanoye, and M. Delacre Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells Clin Exp Immunol 129 2002 429 437
46. J. Estaquier, C. Boutillon, J.C. Ameisen, H. Gras-Masse, J.P. Lecocq, and B. Barbier T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzees Mol Immunol 29 1992 489 499
47. + T cells. I. Influence of antigen concentration and antigen-presenting cell type J Immunol 149 1992 3468 3476
48. R. Matsumoto, M. Matsumoto, S. Mita, Y. Hitoshi, M. Adno, and S. Araki Interleukin-5 inducesmaturation but not class switchingof surface IgA-positive B cells into IgA secreting cells Immunology 66 1989 32 41
49. D.M. Ridley Lathers, R.F. Gill, and P.C. Montgomery Inductive pathways leading to rat tear IgA antibody responses Invest Ophthalmol Vis Sci 39 1998 1005 1011
50. C.D. Partidos, A. Delmas, and M.W. Steward Structural requirements for synthetic immunogens to induce measles virus specific CTL responses Mol Immunol 33 1996 1223 1229
51. C. Bergquist, E.L. Johansson, T. Lagergard, J. Holmgren, and A. Rudin Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina Infect Immun 65 1997 2676 2684